Overview
Managing partner of Fengrui Capital, focusing on investments in the biomedical field, and is also responsible for the operation and management of the fund's Shanghai office. Projects participated in investment and management include Shize Biotechnology, Huayu New Materials, shennong, Zhaoguan Electronics, Jiatlan Microelectronics, etc. Before joining Fengrui Capital, he had more than ten years of experience in investment and M&A. He has successively served as the head of the investment department of Shanghai Pudong Science and Technology Group, deputy general manager of the first investment department of Puko Investment, and business director of Zhangjiang Yaogu Platform. He holds bachelor's and master's degrees in biochemistry and molecular biology from Peking University and an MBA from California State University.
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
峰瑞资本管理合伙人，侧重于生物医药领域的投资，同时也负责基金上海办公室的运营与管理。参与投资并管理的项目包括士泽生物、华渔新材料、shennong、肇观电子、加特兰微电子等。加入峰瑞资本前，拥有十年以上投资与并购工作经验。历任上海浦东科创集团投资部负责人，浦科投资投资一部副总经理，张江药谷平台业务总监。拥有北京大学生物化学与分子生物学学士及硕士学位、美国加州州立大学MBA。